Company registration number 05083409 (England and Wales)
COOMBS HEALTH CARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
PAGES FOR FILING WITH REGISTRAR
COOMBS HEALTH CARE LIMITED
CONTENTS
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 11
COOMBS HEALTH CARE LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 AUGUST 2025
31 August 2025
- 1 -
2025
2024
Notes
£
£
£
£
Non-current assets
Property, plant and equipment
4
1,393,099
1,427,992
Investments
5
2
2
1,393,101
1,427,994
Current assets
Trade and other receivables
7
2,392,253
2,113,602
Cash and cash equivalents
241,683
355,343
2,633,936
2,468,945
Current liabilities
8
(1,478,440)
(1,425,933)
Net current assets
1,155,496
1,043,012
Total assets less current liabilities
2,548,597
2,471,006
Non-current liabilities
10
(560,817)
(591,500)
Provisions for liabilities
Deferred tax liability
11
26,931
23,851
(26,931)
(23,851)
Net assets
1,960,849
1,855,655
Equity
Called up share capital
12
100
100
Retained earnings
13
1,960,749
1,855,555
Total equity
1,960,849
1,855,655
The director of the company has elected not to include a copy of the income statement within the financial statements.true
For the financial year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
COOMBS HEALTH CARE LIMITED
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
31 AUGUST 2025
31 August 2025
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 29 May 2026
Ms N Elliott
Director
Company Registration No. 05083409
COOMBS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
- 3 -
1
Accounting policies
Company information
Coombs Health Care Limited is a private company limited by shares incorporated in England and Wales. The registered office and principal place of business is Wray Park, 55 Alma Road, Reigate, Surrey, RH2 0DN.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.
The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.
1.2
Business combinations
The cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill.
The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date.
Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date.
Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.
1.3
Going concern
Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.
1.4
Revenue
Revenue is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.
COOMBS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 4 -
Revenue from the supply of care services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where payments are received from customers in advance of services provided the amounts are recorded as deferred income and included as part of payables due within one year.
Interest income is recognised when it is probable that the economic benefits will flow to the company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding and the effective interest rate applicable.
1.5
Intangible fixed assets - goodwill
Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.
For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.
1.6
Property, plant and equipment
Property, plant and equipment are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:
Freehold property
50 years straight line
Freehold land is not depreciated.
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.7
Non-current investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.
Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.
COOMBS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 5 -
1.8
Impairment of non-current assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.9
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.10
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
COOMBS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 6 -
Basic financial liabilities
Basic financial liabilities, including trade and other payables, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.11
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.12
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.13
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or non-current assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
COOMBS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 7 -
1.14
Leases
Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.
1.15
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
1
1
3
Intangible fixed assets
Goodwill
£
Cost
At 1 September 2024 and 31 August 2025
310,000
Amortisation and impairment
At 1 September 2024 and 31 August 2025
310,000
Carrying amount
At 31 August 2025
At 31 August 2024
Intangible fixed assets with a carrying amount of £nil (2023: £nil) has been pledged to secure borrowings of the company.
COOMBS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 8 -
4
Property, plant and equipment
Freehold property
£
Cost
At 1 September 2024 and 31 August 2025
1,759,236
Depreciation and impairment
At 1 September 2024
331,244
Depreciation charged in the year
34,893
At 31 August 2025
366,137
Carrying amount
At 31 August 2025
1,393,099
At 31 August 2024
1,427,992
Property, plant and equipment with a carrying amount of £1,393,099 (2024: £1,427,992) has been pledge to secure borrowings of the company.
5
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
2
2
Fixed asset investments with a carrying amount of £2 (2024: £2) has been pledge to secure borrowings of the company.
6
Subsidiaries
Details of the company's subsidiaries at 31 August 2025 are as follows:
Name of undertaking
Registered office
Nature of business
Class of
% Held
shares held
Direct
Indirect
Care Homes of Distinction Limited
England and Wales
Operating care homes for the elderly
Ordinary
100.00
0
7
Trade and other receivables
2025
2024
Amounts falling due within one year:
£
£
Corporation tax recoverable
518,430
518,430
Other receivables
1,873,823
1,595,172
2,392,253
2,113,602
COOMBS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
7
Trade and other receivables
(Continued)
- 9 -
Trade and other receivables with a carrying amount of £2,392,253 (2024: £2,113,602) has been pledged to secure borrowings of the company.
8
Current liabilities
2025
2024
£
£
Bank loans
9
28,636
24,140
Amounts owed to group undertakings
1,394,146
1,360,944
Corporation tax
49,347
22,093
Accruals and deferred income
6,311
18,756
1,478,440
1,425,933
9
Borrowings
2025
2024
£
£
Bank loans
589,453
615,640
Payable within one year
28,636
24,140
Payable after one year
560,817
591,500
The bank loans are secured by a fixed and floating debenture over the assets of the company and a first legal charge over the properties owned by the company.
10
Non-current liabilities
2025
2024
Notes
£
£
Bank loans and overdrafts
9
560,817
591,500
11
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:
Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
26,931
27,527
Tax losses
-
(3,676)
26,931
23,851
COOMBS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
11
Deferred taxation
(Continued)
- 10 -
2025
Movements in the year:
£
Liability at 1 September 2024
23,851
Charge to profit or loss
3,080
Liability at 31 August 2025
26,931
Of the deferred tax liability set out above, an amount of £596 is expected to reverse within 12 months and relates to tax accelerated capital allowances.
12
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
Ordinary shares carry voting rights but have no right to fixed income or fixed repayment of capital.
13
Reserves
Retained earnings
Retained earnings represents cumulative profits or losses, including unrealised profit on the remeasurement of investment properties, net of dividends paid and other adjustments.
14
Controlling party
The company is controlled by the director by virtue of their 100% shareholding of the issued ordinary share capital.
15
Related party transactions
2025
2024
Amounts due to related parties
£
£
Entities over which the entity has control, joint control or significant influence
1,394,146
1,360,944
The following amounts were outstanding at the reporting end date:
2025
2024
Amounts due from related parties
£
£
Key management personnel
1,573,923
1,595,170
Other related parties
299,900
-
COOMBS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 11 -
16
Directors' transactions
Dividends totalling £55,500 (2024: £58,610) were paid in the year in respect of shares held by the company's directors.
As at 31 August 2025, an amount totalling £1,573,923 (2024: £1,595,170) was owed to the company by a director. Interest on this loan is payable at the official rate and the loan is repayable on demand.
2025-08-312024-09-01falsefalsefalse29 May 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMs N ElliottMs N Elliott050834092024-09-012025-08-31050834092025-08-31050834092024-08-3105083409core:LandBuildingscore:OwnedOrFreeholdAssets2025-08-3105083409core:LandBuildingscore:OwnedOrFreeholdAssets2024-08-3105083409core:CurrentFinancialInstrumentscore:WithinOneYear2025-08-3105083409core:CurrentFinancialInstrumentscore:WithinOneYear2024-08-3105083409core:Non-currentFinancialInstrumentscore:AfterOneYear2025-08-3105083409core:Non-currentFinancialInstrumentscore:AfterOneYear2024-08-3105083409core:ShareCapital2025-08-3105083409core:ShareCapital2024-08-3105083409core:RetainedEarningsAccumulatedLosses2025-08-3105083409core:RetainedEarningsAccumulatedLosses2024-08-3105083409core:ShareCapitalOrdinaryShareClass12025-08-3105083409core:ShareCapitalOrdinaryShareClass12024-08-3105083409bus:CompanySecretaryDirector12024-09-012025-08-3105083409core:Goodwill2024-09-012025-08-3105083409core:LandBuildingscore:OwnedOrFreeholdAssets2024-09-012025-08-31050834092023-09-012024-08-3105083409core:NetGoodwill2024-08-3105083409core:NetGoodwill2025-08-3105083409core:NetGoodwill2024-08-3105083409core:LandBuildingscore:OwnedOrFreeholdAssets2024-08-3105083409core:Subsidiary12024-09-012025-08-3105083409core:Subsidiary112024-09-012025-08-3105083409core:CurrentFinancialInstruments2025-08-3105083409core:CurrentFinancialInstruments2024-08-3105083409core:Non-currentFinancialInstruments2025-08-3105083409core:Non-currentFinancialInstruments2024-08-3105083409core:WithinOneYear2025-08-3105083409core:WithinOneYear2024-08-3105083409bus:OrdinaryShareClass12024-09-012025-08-3105083409bus:OrdinaryShareClass12025-08-3105083409bus:OrdinaryShareClass12024-08-3105083409bus:PrivateLimitedCompanyLtd2024-09-012025-08-3105083409bus:SmallCompaniesRegimeForAccounts2024-09-012025-08-3105083409bus:FRS1022024-09-012025-08-3105083409bus:AuditExemptWithAccountantsReport2024-09-012025-08-3105083409bus:Director12024-09-012025-08-3105083409bus:CompanySecretary12024-09-012025-08-3105083409bus:FullAccounts2024-09-012025-08-31xbrli:purexbrli:sharesiso4217:GBP